Object Details
- Genentech, Inc.
- Description (Brief)
- (From box) For single-use IV administration only.
- (From insert)
- RITUXAN is a CD20-directed cytolytic antibody indicated for the treatment of patients with:
- --Non-Hodgkin's Lymphoma
- --Chronic Lymphocytic Leukemia
- --Rheumatoid Arthritis in combination with methotrexate in adult patients with moderately-to severely-active RA who have inadequate response to one or more TNF antagonist therapies
- -Wegener's Granulomatosis and Microscopic Polyangiitis in adult patients in combination with glucocorticoids
- Location
- Currently not on view
- Credit Line
- Gift of Genentech, Inc.
- ca 2013
- product expiration date
- 2015-03
- ID Number
- 2013.0069.10
- catalog number
- 2013.0069.10
- accession number
- 2013.0069
- Object Name
- pharmaceutical
- biological
- Physical Description
- glass (overall material)
- plastic (overall material)
- cardboard (overall material)
- metal (overall material)
- rituximab, 100mg/10mL (overall ingredient)
- Measurements
- overall: 1 1/2 in x 2 3/4 in x 4 1/2 in; 3.81 cm x 6.985 cm x 11.43 cm
- overall: 4 5/8 in x 2 3/4 in x 1 1/2 in; 11.7475 cm x 6.985 cm x 3.81 cm
- place made
- United States: California, South San Francisco
- See more items in
- Medicine and Science: Medicine
- Health & Medicine
- The Antibody Initiative
- Antibody Initiative: Monoclonal Antibodies
- National Museum of American History
- Record ID
- nmah_1445203
- GUID (Link to Original Record)
- https://n2t.net/ark:/65665/ng49ca746ad-e3a9-704b-e053-15f76fa0b4fa
.jpg)
